FAST-CR: Combining a personalized immune cell therapy with radiation for advanced cancers
Part of Cancer, Digestive system, Lungs & breathing, Skin clinical trials.
This study tests a new type of immunotherapy made from your own tumor tissue, combined with radiation therapy. It's for people with advanced or recurrent cancers that have stopped responding to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- Your cancer is advanced or has come back, and standard treatments no longer work.
- You have at least one tumor that can be seen on a scan (not counting tumors that have been surgically removed).
- You are generally well enough to get out of bed and take care of yourself (ECOG score 0-1).
- You don't have HIV, active hepatitis B or C, or other serious infections.
- You have enough tumor tissue (from a surgery or a biopsy) to make the personalized vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation combined with immunotherapy for people with advanced solid tumors that are no longer responding to standard treatments or cannot tolerate them. The goal is to see if this combination can help control the disease.
This trial tests a personalized cancer vaccine combined with a special type of radiation therapy for people with advanced or recurrent cancers that no longer respond to standard treatments. The goal is to help your immune system better recognize and attack your cancer.
This study tests a combination of a personalized vaccine made from your tumor's unique markers, a type of immunotherapy (PD-1 inhibitor), and radiation. The goal is to see if this mix can work better for advanced lung cancer that has progressed after initial treatment.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
This trial tests a personalized vaccine made from “neoantigens” (tumor-specific targets) to help your immune system fight advanced, inoperable solid tumors. It may be an option if standard treatment didn’t work or you stopped it and your health is strong enough for trial treatment.
This trial tests a new immune cell therapy for people with advanced solid tumors of the lung, liver, colon, rectum, or breast. It aims to see if the treatment is safe and can help shrink or control the cancer.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.